ROYAL BANK OF CANADA - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 33 filers reported holding ATYR PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2019$017
-67.3%
0.00%
Q1 2019$0520.0%0.00%
Q4 2018$0520.0%0.00%
Q3 2018$052
+477.8%
0.00%
Q3 2017$09
+28.6%
0.00%
Q1 2017$0
-100.0%
7
-97.9%
0.00%
Q3 2015$3,000
-62.5%
331
-19.5%
0.00%
Q2 2015$8,0004110.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$1,006,0000.85%
VIKING GLOBAL INVESTORS LP 3,209,955$1,766,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 94,466$52,0000.01%
RIVERHEAD CAPITAL MANAGEMENT LLC 79,677$44,0000.00%
WEDBUSH SECURITIES INC 25,999$14,0000.00%
Glen Harbor Capital Management LLC 153,238$84,0000.00%
Tyers Asset Management LLC 72,112$40,0000.00%
Meadow Creek Investment Management LLC 126,196$69,0000.00%
Virtu Financial LLC 41,469$23,0000.00%
Renaissance Technologies 1,540,559$847,0000.00%
View complete list of ATYR PHARMA INC shareholders